Lexaria Bioscience Corp LEXX Q1 2026 Earnings EPS Beat by 38 Despite No Revenue NTRSO Q1 2026 Earnings Strong EPS Beat Amid Cautious Market Sentiment MANH Q1 2026 Earnings EPS Surpasses Estimates as Supply Chain Software Demand Stabilizes Disc Medicine IRON Q1 2026 Earnings SmallerThanExpected Loss Reflects Continued Cost Discipline in PreRevenue Stage SI Q1 2026 Earnings EPS Surprises Above Estimates Amid Limited Revenue Disclosure NG Q1 2026 Earnings Narrowed Loss Beat Estimates as Donlin Gold Project Advances RNST Q1 2026 Earnings EPS Beats Estimates by 811 Stock Declines Slightly TME Q1 2026 Earnings EPS Beat Opaque as Stock Declines Amid Limited Disclosure KPRX Q1 2026 Earnings BetterthanExpected Loss Amid Continued Pipeline Development SFM Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency InflaRx IFRX Q4 2025 Earnings Slight EPS Beat Amid PreRevenue Phase Genmab GMAB Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Data Unavailable FGI Industries Ltd FGI Q1 2026 Earnings Strong EPS Beat Amid Challenging Environment